Continuous Glucose Monitoring Metrics Are Associated With Metabolic Dysfunction–Associated Steatotic Liver Disease and Not Dysglycaemia in Adolescents With Obesity—A Pilot Study
Pediatric Obesity · 2026
DOI: 10.1111/ijpo.70110 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Obesity, 2026. Verfasst von Alapan Mahapatra und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Endocrinology, Regency Center for Diabetes, Endocrinology & Research, Kanpur, India. Hauptthemen laut MEDLINE: Blood Glucose, Pediatric Obesity, Fatty Liver. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 15 Literaturangaben.
Abstract (Originalsprache)
Introduction
The clinical relevance of continuous glucose monitoring (CGM) metrics in adolescents with obesity remains uncertain, particularly in relation to obesity‐related metabolic comorbidities.
Methods
In a pilot study, 39 adolescents with obesity (age 12.9 ± 2.9 years); 29 boys; mean body mass index standard deviation score (BMI SDS; 2.25 ± 0.58) underwent 15 days of CGM along with fasting plasma glucose, oral glucose tolerance testing (OGTT), glycated haemoglobin (HbA1c), and assessment of metabolic comorbidities.
Results
Adolescents with metabolic dysfunction–associated steatotic liver disease (MASLD; n = 5, 12.8%) demonstrated higher median mean amplitude of glycaemic excursion (MAGE; 42.4 vs. 35.2 mg/dL; p = 0.019) and mean of daily difference (MODD; 23.3 vs. 18.5 mg/dL; p = 0.062) compared with those without it. BMI SDS correlated positively with glucose management indicator (GMI; ρ = 0.34, p = 0.041), mean glucose ( ρ = 0.34, p = 0.041), and continuous overall net glycaemic action (CONGA; ρ = 0.38, p = 0.022), whereas fasting glucose, 2‐h OGTT glucose, and HbA1c showed no associations.
Conclusions
In adolescents with obesity, CGM‐derived glycaemic variability metrics were associated with adiposity and MASLD, whereas conventional laboratory measures were not. These findings suggest that CGM may provide complementary information for metabolic phenotyping in paediatric obesity. Longitudinal studies are required to determine implications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Endocrinology, Regency Center for Diabetes, Endocrinology & Research, Kanpur, India.
- Department of Diabetes and Metabolic Disorders, Fortis-C-DOC Centre of Excellence for Diabetes, Metabolic Diseases and Endocrinology, New Delhi, India.
ORCID-Profile: Anoop Misra, Anurag Bajpai
Zitieren
APA
Mahapatra, A., Agarwal, M., Yadav, V., Shukla, P., Misra, A., & Bajpai, A. (2026). Continuous Glucose Monitoring Metrics Are Associated With Metabolic Dysfunction–Associated Steatotic Liver Disease and Not Dysglycaemia in Adolescents With Obesity—A Pilot Study. Pediatric Obesity. https://doi.org/10.1111/ijpo.70110
Vancouver
Mahapatra A, Agarwal M, Yadav V, Shukla P, Misra A, Bajpai A. Continuous Glucose Monitoring Metrics Are Associated With Metabolic Dysfunction–Associated Steatotic Liver Disease and Not Dysglycaemia in Adolescents With Obesity—A Pilot Study. Pediatric Obesity. 2026. doi:10.1111/ijpo.70110
BibTeX
@article{Mahapatra2026,
author = {Mahapatra, Alapan and Agarwal, Manoj and Yadav, Vibha and Shukla, Prashant and Misra, Anoop and Bajpai, Anurag},
title = {Continuous Glucose Monitoring Metrics Are Associated With Metabolic Dysfunction–Associated Steatotic Liver Disease and Not Dysglycaemia in Adolescents With Obesity—A Pilot Study},
journal = {Pediatric Obesity},
year = {2026},
doi = {10.1111/ijpo.70110}
}
EUVIMED